Tumor vaccines stimulate the patients’ immune system, especially the response of specific CD8+ T cells [68]; however, interferon gamma (IFNγ) produced by CD8+ and Th1 CD4+ cells regulate the expression of PD-L1 [108–110]. Here, CD8A is linked to neoplasm.